Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD) (IMPAEPOC)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: December 21, 2010
Last updated: August 8, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Estimated Primary Completion Date: No date given